亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Biomaterials, biological molecules, and polymers in developing vaccines

免疫原性 纳米技术 生物材料 接种疫苗 免疫系统 医学 免疫学 材料科学
作者
Shruthi Polla Ravi,Yasmeen Shamiya,Aishik Chakraborty,Cynthia B. Elias,Arghya Paul
出处
期刊:Trends in Pharmacological Sciences [Elsevier BV]
卷期号:42 (10): 813-828 被引量:20
标识
DOI:10.1016/j.tips.2021.07.006
摘要

Currently, there is an increasing demand for efficacious vaccines for established and emerging infections and diseases. Vaccine formulations can comprise immunogenic antigens, adjuvants, preservatives, and stabilizers. The development of commercial prophylactic vaccines is delayed due to several challenges, such as safety of the formulation, suboptimal immunogenicity, and difficulties in scale-up and storage. Biomaterial-based vaccine candidates have risen to the challenge, successfully overcoming various limitations of traditional vaccines in preclinical and clinical trials. By applying the principles of polymer chemistry and bioscience, these biomaterial-based vaccines make use of chemically modified polymers, proteins, and hydrogels, as well as biomimetic virus-like nanoparticles and cell membranes, to achieve the desired levels of both safety and immunogenicity. Vaccines have been used to train the immune system to recognize pathogens, and prevent and treat diseases, such as cancer, for decades. However, there are continuing challenges in their manufacturing, large-scale production, and storage. Some of them also show suboptimal immunogenicity, requiring additional adjuvants and booster doses. As an alternate vaccination strategy, a new class of biomimetic materials with unique functionalities has emerged in recent years. Here, we explore the current bioengineering techniques that make use of hydrogels, modified polymers, cell membranes, self-assembled proteins, virus-like particles (VLPs), and nucleic acids to deliver and develop biomaterial-based vaccines. We also review design principles and key regulatory issues associated with their development. Finally, we critically assess their limitations, explore approaches to overcome these limitations, and discuss potential future applications for clinical translation. Vaccines have been used to train the immune system to recognize pathogens, and prevent and treat diseases, such as cancer, for decades. However, there are continuing challenges in their manufacturing, large-scale production, and storage. Some of them also show suboptimal immunogenicity, requiring additional adjuvants and booster doses. As an alternate vaccination strategy, a new class of biomimetic materials with unique functionalities has emerged in recent years. Here, we explore the current bioengineering techniques that make use of hydrogels, modified polymers, cell membranes, self-assembled proteins, virus-like particles (VLPs), and nucleic acids to deliver and develop biomaterial-based vaccines. We also review design principles and key regulatory issues associated with their development. Finally, we critically assess their limitations, explore approaches to overcome these limitations, and discuss potential future applications for clinical translation. a family of bacterial toxins comprising a single catalytically active A-subunit and a pentamer of B-subunits capable of mediating receptor binding and delivery of a toxin to the target cell. a drug or substance that can, in combination with other drugs/substances, increase the efficacy or potency of drugs. a group of immune cells that cause a cellular immune response by processing and presenting antigens on the surface for recognition by lymphocytes. molecules produced by cells and living organisms that are essential for one or more biological process. a material or a combination of materials, natural or synthetic, that are modified by the application of engineering principles so that they can be introduced into, and interact with, biological systems. the proteins that make up the shell of a virus, enclosing the virus genetic material and protecting it from degradation. an inorganic or organometallic polymer containing metal centers connected by a ligand. a type of APC that processes and presents antigens to T cells, giving rise to a cellular immune response. a globular iron storage protein made up of 24 subunits that form a nanocage with multiple metal–protein interactions. a hormone that causes the pituitary gland of the brain to release follicle-stimulating hormone and luteinizing hormone. the methods and regulations implemented to ensure the production of good-quality pharmaceutical products and to control the manufacture process to reduce variability and contamination. a particle that has a size of 1–100 nm in at least two dimensions. a class of antigens caused by mutations in the tumor cell genome that appear in tumor cells but not in normal tissues. Neoantigens show individual specificity, are highly immunogenic, and elicit stable therapeutic effects. a large, complex, and mildly immunogenic glycoprotein; a key reference protein for vaccination experiments as an antigen for immunization research. a process in which protective cells (phagocytes) engulf and degrade harmful foreign particles, bacteria, or dead/dying cells, clearing them from the body. a copolymer approved by the US Food and Drug Administration for therapeutic devices due to its biodegradability and biocompatibility. a polymer with repeating units comprising an amine group and two carbon aliphatic CH2CH2 spacers; can be used as an adjuvant due to its ability to elicit a strong immune response. a preventative vaccine that involves the introduction of antigens into the body with the intention of creating antibodies for those antigens, such that the individual becomes immune to the associated illness. a process used to evaluate and control the quality of a pharmaceutical product, and to review its risks throughout the life cycle of the product; performed to ensure that the benefits outweigh the risks, and that the end user is not harmed in any way. an important type of lymphocyte (white blood cell) that has a key role in the adaptive immune response. a vaccine that involves the introduction of antigens into the body after the occurrence of an infection or disease to force the immune system to generate antibodies against those antigens, thereby curing the individual of the associated illness. a class of pattern recognition receptors that cause an immune response by recognizing conserved molecular patterns for early immune recognition of a pathogen.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
2秒前
2秒前
复杂的万恶完成签到,获得积分10
4秒前
认真的龙猫完成签到 ,获得积分10
6秒前
11秒前
贱小贱完成签到,获得积分0
11秒前
me6363发布了新的文献求助10
16秒前
139完成签到 ,获得积分10
21秒前
无极微光的应助被行必至采纳,获得20
29秒前
科研通AI6.2的应助被萧雨墨采纳,获得10
36秒前
飘逸的安珊完成签到,获得积分10
41秒前
41秒前
飞快的不尤完成签到,获得积分10
42秒前
Jazz33333333完成签到,获得积分10
42秒前
1874发布了新的文献求助10
47秒前
shentaii完成签到,获得积分0
48秒前
果枳完成签到,获得积分10
53秒前
行必至完成签到,获得积分20
1分钟前
萧雨墨发布了新的文献求助10
1分钟前
香蕉觅云的应助被1874采纳,获得10
1分钟前
张阳发布了新的文献求助10
1分钟前
萧雨墨发布了新的文献求助10
1分钟前
情怀的应助被Lihedou采纳,获得10
1分钟前
1分钟前
1分钟前
Lihedou发布了新的文献求助10
2分钟前
萧雨墨发布了新的文献求助10
2分钟前
Maestro_S的应助被abc采纳,获得10
2分钟前
2分钟前
Jun的应助被科研通管家采纳,获得10
2分钟前
2分钟前
Jun的应助被科研通管家采纳,获得10
2分钟前
科研通AI65的应助被高速公鹿采纳,获得10
2分钟前
kyokyoro完成签到,获得积分10
2分钟前
在水一方的应助被渟柠采纳,获得20
2分钟前
wsws完成签到 ,获得积分10
2分钟前
2分钟前
萧雨墨发布了新的文献求助10
2分钟前
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190117
求助须知:如何正确求助?哪些是违规求助? 9577222
关于积分的说明 21852176
捐赠科研通 7788406
什么是DOI,文献DOI怎么找? 3436259
关于科研通互助平台的介绍 2559994
邀请新用户注册赠送积分活动 2482862